Clinical Trial Update: A Study of AL102 in Patients With Progressing Desmoid Tumors [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating AL102 in patients with progressing desmoid-type fibromatosis (desmoid tumors) is ongoing and currently ACTIVE_NOT_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis

Drugs mentioned

• AL102

Snippet

Sponsor: Immunome, Inc. | Conditions: Desmoid, Desmoid Tumor | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING